AU
Aurinia Pharmaceuticals Inc.
AUPH · NASDAQ
$16.67 -0.24% (-$0.04)
1M +0.60%
Market Cap $2.14B
P/E Ratio 6.82x
Div. Yield -
ROE 59.00%
Bulios Fair Price
$23.43
40.6% upside
Trenutna cena
$16.67
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica AUPH trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
6/9Valuation
80 /100
Cheap PEG 0.00x
P/E 6.82x
P/B 3.49x
Growth
99 /100
Growing Book val. growth 12.76%
Rev. growth 28.30%
FCF growth N/A
Profitability
100 /100
Strong Op. margin 48.39%
Gross margin 90.36%
FCF margin 55.72%
Quality
90 /100
Excellent ROA 39.65%
ROIC 41.66%
Asset turnover 0.39x
Debt
100 /100
Low Int. coverage 19.92x
Debt/Equity 0.10x
Net debt/EBITDA -0.63x
Stability
46 /100
Moderate EPS volatility 2,944.21%
Beta 1.41x
Profitable years 2
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o AUPH
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Kevin C. Tang
Employees
128
Headquarters
Edmonton
Prihajajoči dogodki
03 NOV.
Earnings
Upcoming earnings report